Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil in Chinese Subjects with Compensated Chronic Hepatitis B
NCT00441974Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by GSK. Primary endpoint: Proportion of Subjects Achieving HBV DNA Undetectable (<1000 copies/mL) at 48 weeks. Started Dec 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00441974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441974.